A Comparison between the Compass Fundus Perimeter and the Humphrey Field Analyzer
Purpose: To evaluate relative diagnostic precision and testeretest variability of 2 devices, the Compass (CMP, CenterVue, Padova, Italy) fundus perimeter and the Humphrey Field Analyzer (HFA, Zeiss, Dublin, CA), in detecting glaucomatous optic neuropathy (GON).
Design: Multicenter, cross-sectional, case-control study.
Participants: We sequentially enrolled 499 patients with glaucoma and 444 normal subjects to analyze relative precision. A separate group of 44 patients with glaucoma and 54 normal subjects was analyzed to assess test-retest variability.
Methods: One eye of recruited subjects were tested with the index tests: HFA (Swedish interactive thresholding algorithm [SITA] standard strategy) and CMP (Zippy Estimation by Sequential Testing [ZEST] strategy), 24-2 grid. The reference test for GON was specialist evaluation of fundus photographs or OCT, independent of the visual field (VF). For both devices, linear regression was used to calculate the sensitivity decrease with age in the normal group to compute pointwise total deviation (TD) values and mean deviation (MD). We derived 5% and 1% pointwise normative limits. The MD and the total number of TD values below 5% (TD 5%) or 1% (TD 1%) limits per field were used as classifiers.
Main Outcome Measures: We used partial receiver operating characteristic (pROC) curves and partial area under the curve (pAUC) to compare the diagnostic precision of the devices. Pointwise mean absolute deviation and BlandeAltman plots for the mean sensitivity (MS) were computed to assess test-retest variability.
Results: Retinal sensitivity was generally lower with CMP, with an average mean difference of 1.85±0.06 decibels (dB) (mean ±standard error, P < 0.001) in healthy subjects and 1.46±0.05 dB (mean ±standard error, P < 0.001) in patients with glaucoma. Both devices showed similar discriminative power. The MD metric had
marginally better discrimination with CMP (pAUC difference ±standard error, 0.019±0.009, P ¼ 0.035). The 95% limits of agreement for the MS were reduced by 13% in CMP compared with HFA in participants with glaucoma and by 49% in normal participants. Mean absolute deviation was similar, with no significant differences.
Conclusions: Relative diagnostic precision of the 2 devices is equivalent. Testeretest variability of MS for CMP
was better than for HFA. Ophthalmology 2019;126:242-251 ª 2018 by the American Academy of Ophthalmology
Find FULL article HERE